Aratana Therapeutics
Latest round
- Series C
Last raised
- Jan 2013
Total raised
- $56M
Investors
- 8
About Aratana Therapeutics
Established in 2010 and based in Kansas, US, Aratana Therapeutics, Inc. operates as a developer of therapeutics for dogs and cats. The company offers Galliprant® which used for pain relief to early diagnosed stages of Osteoarthritis, ENTYCE® which is used in restoring appetite and NOCITA®, an injectible post-surgical pain relief.
Who invested in Aratana Therapeutics
8 investors across 4 rounds
See all investors in Aratana Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aratana Therapeutics
Who invested in Aratana Therapeutics?
Aratana Therapeutics has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aratana Therapeutics raised?
Aratana Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Aratana Therapeutics last raise money?
Aratana Therapeutics's most recent round on record is a Series C, in Jan 2013.
What does Aratana Therapeutics do?
Established in 2010 and based in Kansas, US, Aratana Therapeutics, Inc.
Where is Aratana Therapeutics headquartered?
Aratana Therapeutics is headquartered in Leawood, US.
Which VCs invest in companies like Aratana Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Aratana Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Aratana Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.